TFC Financial Management Inc. Lowers Position in UnitedHealth Group Incorporated (NYSE:UNH)

TFC Financial Management Inc. lessened its position in UnitedHealth Group Incorporated (NYSE:UNH) by 3.4% in the fourth quarter, HoldingsChannel reports. The firm owned 656 shares of the healthcare conglomerate’s stock after selling 23 shares during the quarter. TFC Financial Management Inc.’s holdings in UnitedHealth Group were worth $332,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Ingalls & Snyder LLC lifted its stake in shares of UnitedHealth Group by 1.7% in the 4th quarter. Ingalls & Snyder LLC now owns 8,670 shares of the healthcare conglomerate’s stock valued at $4,386,000 after purchasing an additional 143 shares during the period. McClarren Financial Advisors Inc. increased its position in UnitedHealth Group by 62.7% during the 4th quarter. McClarren Financial Advisors Inc. now owns 1,533 shares of the healthcare conglomerate’s stock valued at $775,000 after buying an additional 591 shares in the last quarter. Hidden Cove Wealth Management LLC bought a new position in UnitedHealth Group during the 4th quarter valued at approximately $214,000. Naples Global Advisors LLC increased its position in UnitedHealth Group by 3.0% during the 4th quarter. Naples Global Advisors LLC now owns 14,468 shares of the healthcare conglomerate’s stock valued at $7,319,000 after buying an additional 428 shares in the last quarter. Finally, Van ECK Associates Corp increased its position in UnitedHealth Group by 12.6% during the 4th quarter. Van ECK Associates Corp now owns 196,907 shares of the healthcare conglomerate’s stock valued at $99,607,000 after buying an additional 22,059 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

A number of analysts have commented on the company. Stephens lifted their target price on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a report on Thursday, December 5th. Oppenheimer lifted their target price on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Morgan Stanley reduced their target price on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. Piper Sandler dropped their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. Finally, Barclays dropped their price target on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research note on Friday, January 17th. One equities research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Stock Down 1.2 %

UnitedHealth Group stock opened at $527.31 on Thursday. The business has a fifty day moving average of $526.25 and a two-hundred day moving average of $563.96. The firm has a market cap of $485.27 billion, a P/E ratio of 34.02, a P/E/G ratio of 1.45 and a beta of 0.61. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same period last year, the firm earned $5.83 EPS. The firm’s revenue for the quarter was up 6.8% compared to the same quarter last year. On average, analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Insider Activity at UnitedHealth Group

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction dated Friday, January 17th. The stock was acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.33% of the stock is currently owned by corporate insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.